Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-015830
Filing Date
2010-03-26
Accepted
2010-03-26 13:01:08
Documents
19
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v178700_10k.htm 10-K 1886494
2 GRAPHIC logo1.jpg GRAPHIC 7030
3 GRAPHIC logo2.jpg GRAPHIC 12228
4 GRAPHIC pg12.jpg GRAPHIC 87119
5 GRAPHIC pg13.jpg GRAPHIC 60032
6 GRAPHIC pg14a.jpg GRAPHIC 100792
7 GRAPHIC pg14b.jpg GRAPHIC 103940
8 GRAPHIC pg15.jpg GRAPHIC 90056
9 GRAPHIC pg8a.jpg GRAPHIC 34253
10 GRAPHIC pg8b.jpg GRAPHIC 31910
11 v178700_ex21.htm EX-21 2600
12 v178700_ex23-1.htm EX-23.1 5825
13 GRAPHIC footer.jpg GRAPHIC 17927
14 GRAPHIC header1.jpg GRAPHIC 6608
15 GRAPHIC header2.jpg GRAPHIC 15210
16 v178700_ex31-1.htm EX-31.1 14166
17 v178700_ex31-2.htm EX-31.2 14156
18 v178700_ex32-1.htm EX-32.1 7061
19 v178700_ex32-2.htm EX-32.2 7089
  Complete submission text file 0001144204-10-015830.txt   2721959
Mailing Address 3 SAPIR STREET WEIZMANN SCIENCE PARK NES-ZIONA L3 74140
Business Address 3 SAPIR STREET WEIZMANN SCIENCE PARK NES-ZIONA L3 74140 (866) 644-7811
PROLOR Biotech, Inc. (Filer) CIK: 0001268659 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52691 | Film No.: 10706921
SIC: 2834 Pharmaceutical Preparations